Goldman Sachs upgraded Johnson & Johnson (NYSE: JNJ) from Sell to Neutral with a price target of $134.00 (from $127.00).Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE